Stock CSBR CHAMPIONS ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Champions Oncology, Inc.

Equities

CSBR

US15870P3073

Delayed Nasdaq
Other stock markets
 02:37:22 2024-06-10 pm EDT 		5-day change 1st Jan Change
4.75 USD +3.26% Intraday chart for Champions Oncology, Inc. -0.42% -15.48%
Jun. 04 Champions Oncology, Inc and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development CI
Mar. 15 Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Craig-Hallum Downgrades Champions Oncology to Hold From Buy
MT
Craig Hallum Trims Champions Oncology Price target to $9 From $10, Maintains Buy Rating
MT
Roth MKM Adjusts Price Target on Champions Oncology to $7.50 From $9, Maintains Buy Rating
MT
Benchmark Company Downgrades Champions Oncology to Hold From Speculative Buy
MT
Craig Hallum Adjusts Champions Oncology Price Target to $10 From $12, Maintains Buy Rating
MT
CHAMPIONS ONCOLOGY : Roth Capital Adjusts Price Target on Champions Oncology to $16 From $13.50, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CSBR Stock
  4. News Champions Oncology, Inc.
  5. Analyst Reco.